|
| | 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide Basic information |
| Product Name: | 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide | | Synonyms: | 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide;2-(2-butyl-4-Methyl-6-oxo-1-((2'-(1-phenyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-1,6-dihydropyriMidin-5-yl)-N,N-diMethylacetaMide coMpound with 1,1'-biphenyl (1:1);2-(2-butyl-4-Methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-1,6-dihydropyriMidin-5-yl)-N,N-diMethylacetaMide;Fimasartan Impurity D;Fimasartan Impurity 3;Fimasartan-3;2-butyl-1,6-dihydro-N, N, 4-trimethyl-6-oxo-1-[[2 '-[1- (trityl) -1H-tetrazole- 5-yl] [1,1'-biphenyl] -4-yl] methyl] -5-pyrimidineacetamide;5-Pyrimidineacetamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]- | | CAS: | 503155-67-7 | | MF: | C46H45N7O2 | | MW: | 727.9 | | EINECS: | | | Product Categories: | | | Mol File: | 503155-67-7.mol | ![2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide Structure](CAS/20180906/GIF/503155-67-7.gif) |
| | 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide Chemical Properties |
| Boiling point | 882.1±75.0 °C(Predicted) | | density | 1.17 | | pka | 1.36±0.70(Predicted) |
| | 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide Usage And Synthesis |
| | 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide Preparation Products And Raw materials |
|